What is mattwood.fyi?

A live, structured feed of riffs and links from Matt Wood, Chief AI & Technology Officer at AWS — readable by people and queryable by agents as a typed knowledge graph.

Is there an API and is it free?

Yes. A public, read-only query API is available with no authentication and no API keys. See https://mattwood.fyi/openapi.json and https://mattwood.fyi/docs.

How should an AI agent use this site?

Fetch https://mattwood.fyi/feed.json for the full structured feed, or query the API for keyword/semantic search and the connection graph. See https://mattwood.fyi/agents/ for when-to-use guidance.

Daphne Koller: Insitro, AI-Driven Drug Discovery, and the Virtual Human Platform

Recent milestones (2026): - June 8, 2026: Presented at ADA 86th Scientific Sessions showing CTRO-1013 (liver-targeted IRS1 siRNA) reduces fibrosis biomarkers TIMP-1 (37%) and CK-18 (68%) in preclinical models, with effects partly independent of fat reduction - March 2026: Expanded BMS collaboration for ALS/FTD with nomination of new targets - Janua

www.linkedin.com →

Connections

Supports

Inertia-1: Unified Motion Foundation Model from Wearable Sensors Insitro's domain-specific biology foundation model strategy echoes Inertia-1's approach of building a unified foundation model for a single physical domain, motion.

Lessons from Anthropic's Head of Product on AI Product Development | Lenny Rachitsky posted on the topic | LinkedIn Anthropic's product-development lessons on deploying AI responsibly parallel Koller's challenge of productizing AI-driven drug discovery at Insitro.
NVIDIA CEO Jensen Huang on American Innovation | Ylli Bajraktari posted on the topic | LinkedIn Huang's narrative on American AI-driven innovation parallels Koller's presentation of AI-powered drug discovery as a concrete application of that innovation wave.
Discovery Loop Both companies apply AI and computational infrastructure to accelerate scientific discovery loops — Insitro focuses on drug discovery with virtual human platforms while Discovery Loop automates experimental loops across science and engineering broadly
LLMs can't jump Daphne Koller's AI-driven drug discovery via 'Virtual Human Platform' is a domain where manipulative abduction and physical simulation are explicitly required — the item's thesis has direct implications for the limits of LLM contribution to scientific drug discovery.
Open Athena Insitro's AI-driven drug discovery mission shares the academic-industry bridge model with Open Athena — both demonstrate nonprofit/mission-driven organizations deploying foundation models in specialized domains with institutional partnerships

Type:	link
First published:	Saturday, 4 July 2026 at 12:00 UTC
Location:	https://www.linkedin.com/posts/daphne-koller-4053a820_ai-share-7479398759638949888-hHpv/
URL:	https://mattwood.fyi/i/50220616

I'm Matt Wood, and this is For Your Information. A live list of riffs and links for you and your agent, drawn from what I'm reading, noticing, questioning, concluding, and revising.

Connections